Follow
Robert Zeiser
Robert Zeiser
Professor of Medicine, University of Freiburg
Verified email at uniklinik-freiburg.de - Homepage
Title
Cited by
Cited by
Year
Acute graft-versus-host disease—biologic process, prevention, and therapy
R Zeiser, BR Blazar
New England Journal of Medicine 377 (22), 2167-2179, 2017
10412017
Origin, fate and dynamics of macrophages at central nervous system interfaces
T Goldmann, P Wieghofer, MJC Jordão, F Prutek, N Hagemeyer, ...
Nature immunology 17 (7), 797-805, 2016
10112016
International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium
AC Harris, R Young, S Devine, WJ Hogan, F Ayuk, U Bunworasate, ...
Biology of Blood and Marrow Transplantation 22 (1), 4-10, 2016
6132016
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
R Zeiser, A Burchert, C Lengerke, M Verbeek, K Maas-Bauer, ...
Leukemia 29 (10), 2062-2068, 2015
5842015
Inhibition of CD4+ CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production
R Zeiser, VH Nguyen, A Beilhack, M Buess, S Schulz, J Baker, CH Contag, ...
Blood 108 (1), 390-399, 2006
5652006
Pathophysiology of chronic graft-versus-host disease and therapeutic targets
R Zeiser, BR Blazar
New England Journal of Medicine 377 (26), 2565-2579, 2017
5642017
Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease
R Zeiser, N von Bubnoff, J Butler, M Mohty, D Niederwieser, R Or, J Szer, ...
New England Journal of Medicine 382 (19), 1800-1810, 2020
5432020
Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R
K Wilhelm, J Ganesan, T Müller, C Dürr, M Grimm, A Beilhack, CD Krempl, ...
Nature medicine 16 (12), 1434-1438, 2010
4862010
Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells
R Zeiser, DB Leveson-Gower, EA Zambricki, N Kambham, A Beilhack, ...
Blood, The Journal of the American Society of Hematology 111 (1), 453-462, 2008
4382008
Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment
G Mikhaylov, U Mikac, AA Magaeva, VI Itin, EP Naiden, I Psakhye, ...
Nature nanotechnology 6 (9), 594-602, 2011
4282011
Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease
S Spoerl, NR Mathew, M Bscheider, A Schmitt-Graeff, S Chen, T Mueller, ...
Blood, The Journal of the American Society of Hematology 123 (24), 3832-3842, 2014
4252014
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European …
O Penack, M Marchetti, T Ruutu, M Aljurf, A Bacigalupo, F Bonifazi, ...
The Lancet Haematology 7 (2), e157-e167, 2020
4112020
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation …
A Burchert, G Bug, LV Fritz, J Finke, M Stelljes, C Röllig, E Wollmer, ...
Journal of Clinical Oncology 38 (26), 2993-3002, 2020
3872020
CD4+ T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation
K Rakhra, P Bachireddy, T Zabuawala, R Zeiser, L Xu, A Kopelman, ...
Cancer cell 18 (5), 485-498, 2010
3702010
Immunodominance and functional alterations of tumor‐associated antigen‐specific CD8+ T‐cell responses in hepatocellular carcinoma
T Flecken, N Schmidt, S Hild, E Gostick, O Drognitz, R Zeiser, ...
Hepatology 59 (4), 1415-1426, 2014
3382014
Continuous T cell receptor signals maintain a functional regulatory T cell pool
JC Vahl, C Drees, K Heger, S Heink, JC Fischer, J Nedjic, N Ohkura, ...
Immunity 41 (5), 722-736, 2014
3272014
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation
C Toffalori, L Zito, V Gambacorta, M Riba, G Oliveira, G Bucci, M Barcella, ...
Nature medicine 25 (4), 603-611, 2019
2982019
Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
AM Paczulla, K Rothfelder, S Raffel, M Konantz, J Steinbacher, H Wang, ...
Nature 572 (7768), 254-259, 2019
2932019
Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage
L Schwab, L Goroncy, S Palaniyandi, S Gautam, A Triantafyllopoulou, ...
Nature medicine 20 (6), 648-654, 2014
2932014
In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation
VH Nguyen, R Zeiser, DL DaSilva, DS Chang, A Beilhack, CH Contag, ...
Blood 109 (6), 2649-2656, 2007
2682007
The system can't perform the operation now. Try again later.
Articles 1–20